Modified FOLFIRINOX versus sequential chemotherapy (FOLFIRI/FOLFOX) as second-line treatment for advanced pancreatic adenocarcinoma: A real-world analysis.

Shun Tezuka,Makoto Ueno,Satoshi Kobayashi,Manabu Morimoto,Shuhei Nagashima,Yusuke Sano,Hiroyuki Asama,Kuniyuki Kawano,Satoshi Tanaka,Taito Fukushima

Modified FOLFIRINOX versus sequential chemotherapy (FOLFIRI/FOLFOX) as second-line treatment for advanced pancreatic adenocarcinoma: A real-world analysis.

2020

Shun Tezuka
Makoto Ueno
Satoshi Kobayashi
Manabu Morimoto
Shuhei Nagashima
Yusuke Sano
Hiroyuki Asama
Kuniyuki Kawano
Satoshi Tanaka
Taito Fukushima

711Background: Therapy options for second-line treatment of advanced pancreatic adenocarcinoma (PDAC) are limited and preferred regimens have not been established. This study compared the efficacy ...

Keywords:

FOLFIRINOX
FOLFIRI
Adenocarcinoma
Internal medicine
FOLFOX
Chemotherapy
Oncology
Medicine
Pathology
second line treatment
sequential chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations